Mario Jendrossek

Safety and long-term immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Sierra Leone: a combined open-label, non-randomised stage 1, and a randomised, double-blind, controlled stage 2 trial

David Ishola, Daniela Manno, Muhammed O. Afolabi et al. · The Lancet Infectious Diseases · 2021 · 95 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +13

Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in children in Sierra Leone: a randomised, double-blind, controlled trial

Muhammed O. Afolabi, David Ishola, Daniela Manno et al. · The Lancet Infectious Diseases · 2021 · 93 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +14

Residential Air Pollution, Road Traffic, Greenness and Maternal Hypertension: Results from GINIplus and LISAplus

Mario Jendrossek, Marie Standl, Sibylle Koletzko et al. · The International Journal of Occupational and Environmental Medicine · 2017 · 30 citations · Full text

Public Health, Environmental Sciences, Maternal Health +17

Health care worker vaccination against Ebola: Vaccine acceptance and employment duration in Sierra Leone

Mario Jendrossek, W. John Edmunds, Hana Rohan et al. · Vaccine · 2019 · 22 citations · Full text

Medicine, Infectious Diseases, Preventive Medicine +15

Lessons Learned From European Health Data Projects With Cancer Use Cases: Implementation of Health Standards and Internet of Things Semantic Interoperability

Amélie Gyrard, Somayeh Abedian, Philip Gribbon et al. · Journal of Medical Internet Research · 2025 · 16 citations · Full text

Computing, Biomedical Informatics, Health Informatics +17